Auf dieser Seite
IMDX Insight Molecular Diagnostics Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 10, 2026
$3,44
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,4252-Wochen-Tief
$8,5152-Wochen-Hoch
Marktkapitalisierung (MRQ)
$112M
P/E (TTM)
-2.3
EPS (TTM)
$-1.52
Umsatz (TTM)
$2M
Ihre Abzeichen
52W-Spanne
$2–$9
Analystenbewertung
BUY
Kursziel
$8
P/E
-2.3
ROE
488.7%
Nettogewinnmarge
-2955.6%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
IMDX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$3.44
Marktkapitalisierung (MRQ)
$112M
P/E (TTM)
-2.3
EPS (TTM)
$-1.52
Umsatz (TTM)
$2M
ROE (TTM)
488.7%
52W-Spanne
$2–$9
IMDX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 25. Juli 2023 | 1-for-20 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$4M2020-12-31 → 2025-12-31
EPS$-1.652022-12-31 → 2025-12-31
Freier Cashflow$-25M2016-12-31 → 2025-12-31
Nettogewinnmarge-2955.6%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | IMDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -2.35-Jahres-Durchschnitt ≈-1.6 | ≈-1.6 | · | · | |
| P/S (TTM) | 67.25-Jahres-Durchschnitt ≈29.6 | ≈29.6 | 43.3 | Überbewertet | |
| K/B (MRQ) | -5.35-Jahres-Durchschnitt ≈-3.1 | ≈-3.1 | · | · | |
| Kurs / FCF (TTM) | -3.65-Jahres-Durchschnitt ≈-3.8 | ≈-3.8 | · | · | |
| Kurs / Cashflow (TTM) | -4.25-Jahres-Durchschnitt ≈-4.2 | ≈-4.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | IMDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 47.6%5-Jahres-Durchschnitt ≈41.2% | ≈41.2% | · | · | |
| Betriebsgewinnmarge (TTM) | -3011.9%5-Jahres-Durchschnitt ≈-2059.4% | ≈-2059.4% | -583.5% | Schwach | |
| EBITDA-Marge (TTM) | -2865.6%5-Jahres-Durchschnitt ≈-2013.7% | ≈-2013.7% | -583.5% | Schwach | |
| Nettogewinnmarge (TTM) | -2955.6%5-Jahres-Durchschnitt ≈-2104.0% | ≈-2104.0% | -597.4% | Schwach | |
| ROA (TTM) | -123.5%5-Jahres-Durchschnitt ≈-102.4% | ≈-102.4% | -54.3% | Schwach | |
| ROE (TTM) | 488.7%5-Jahres-Durchschnitt ≈1655.5% | ≈1655.5% | -61.8% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | IMDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.05-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 7.7 | Geringe Liquidität | |
| Quick Ratio | 1.15-Jahres-Durchschnitt ≈1.3 | ≈1.3 | 7.5 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | IMDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 115.6%5-Jahres-Durchschnitt ≈44.4% | ≈44.4% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 61.8%5-Jahres-Durchschnitt ≈21.3% | ≈21.3% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 27.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | IMDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.1 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 4.1 | · | · | · | |
| Receivables Turnover (Forderungsumschlag) | 3.05-Jahres-Durchschnitt ≈2.5 | ≈2.5 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$73.7K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-86.3%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-0.31 | $-0.25 | -24.4% |
| 31. März 2026 | Mai 13, 2026 | $-0.12 | $-0.27 | 55.0% |
| 31. Dezember 2025 | $-0.72 | $-0.24 | -197.5% | |
| 30. September 2025 | $-0.34 | $-0.21 | -59.0% | |
| 30. Juni 2025 | $-0.30 | $-0.23 | -27.9% | |
| 31. März 2025 | $-0.26 | $-0.24 | -7.8% | |
| 31. Dezember 2024 | $-1.93 | $-0.44 | -342.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $2M | $2M | $958.0K | $2M | $1M | · | · | · | · | $0 | |
| Cost of Revenue | $2M | $1M | $1M | $880.0K | $697.0K | $2M | · | · | · | · | · | |
| Gross Profit | $2M | $740.0K | $413.0K | $-18.0K | $1M | $-639.0K | · | · | · | · | · | |
| R&D Expense | $16M | $10M | $9M | $7M | $5M | $10M | $7M | $7M | $7M | $6M | $5M | |
| SG&A Expense | $11M | $10M | $11M | $22M | $22M | $17M | $13M | $7M | $9M | $4M | $4M | |
| Operating Expenses | $53M | $62M | $26M | $18M | $55M | $29M | $22M | $15M | $19M | $11M | $9M | |
| Operating Income | $-51M | $-61M | $-25M | $-18M | $-54M | $-30M | $-22M | $-15M | $-19M | $-11M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | $18.0K | |
| Other Non-op | $1M | $462.0K | $394.0K | $-61.0K | $-37.0K | $27.0K | $-3.0K | $91.0K | $-309.0K | $0 | $2.0K | |
| Pretax Income | · | $-61M | $-25M | $-19M | $-53M | $-31M | $-22M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | · | $-9M | $-1M | · | · | · | · | · | |
| Net Income | $-50M | $-61M | $-28M | $-73M | $-64M | $-30M | $-22M | $-16M | $-19M | $-11M | $-9M | |
| EPS (Basic) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | $-0.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · | · | · | · | · | · | · | |
| Shares (Basic) | 30,476,000 | 13,071,000 | 7,651,000 | 5,540,000 | 88,920 | · | · | · | · | · | · | |
| Shares (Diluted) | 30,476,000 | 13,071,000 | 7,651,000 | 5,540,000 | · | · | · | · | · | · | · | |
| EBITDA | $-49M | $-59M | $-25M | · | · | · | · | · | · | $-11M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $9M | $9M | $20M | $33M | $7M | $22M | $8M | $8M | $10M | $8M | |
| Receivables | $1M | $2M | $484.0K | $2M | $1M | $203.0K | · | · | · | · | · | |
| Inventory | $446.0K | $410.0K | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $821.0K | $643.0K | $977.0K | $901.0K | $1M | $505.0K | $180.0K | $168.0K | $285.0K | $388.0K | |
| Other Current Assets | · | · | · | · | $85.0K | $295.0K | $36.0K | $78.0K | · | $103.0K | $22.0K | |
| Current Assets | $15M | $12M | $11M | $26M | $39M | $9M | $23M | $9M | $9M | $13M | $11M | |
| PP&E (Net) | $6M | $6M | $5M | $9M | $7M | $4M | $4M | $614.0K | $822.0K | $688.0K | $576.0K | |
| PP&E (Gross) | · | · | · | · | $7M | $2M | $1M | $2M | $1M | $1M | $750.0K | |
| Accum. Depreciation | $7M | $8M | $6M | $4M | $3M | $1M | $343.0K | $948.0K | $657.0K | $319.0K | $174.0K | |
| Goodwill | · | · | · | · | $19M | $9M | · | · | · | · | · | |
| Intangibles | $0 | $15M | $57M | $62M | $62M | $15M | · | · | $746.0K | $988.0K | $1M | |
| Other Non-current Assets | $593.0K | $691.0K | $463.0K | $371.0K | $264.0K | $356.0K | $93.0K | · | · | · | · | |
| Total Assets | $26M | $35M | $75M | $100M | $160M | $55M | $40M | $10M | $10M | $14M | $13M | |
| Accounts Payable | $3M | $2M | $953.0K | $1M | $2M | $432.0K | $469.0K | $166.0K | $175.0K | $422.0K | $285.0K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $3M | $3M | · | · | $636.0K | $549.0K | $325.0K | |
| Current Liabilities | $12M | $7M | $7M | $12M | $14M | $9M | $4M | $6M | $4M | $4M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | $187.0K | $289.0K | $310.0K | $0 | |
| Total Liabilities | $57M | $47M | $49M | $60M | $94M | $22M | $9M | $6M | $6M | $5M | $2M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $2M | · | · | |
| Common Stock | $369M | $338M | $310M | $295M | $253M | $157M | $125M | $75M | $60M | $46M | $35M | |
| Retained Earnings | $-401M | $-351M | $-290M | $-261M | $-188M | $-124M | $-94M | $-71M | $-55M | $-35M | $-24M | |
| AOCI | $86.0K | $21.0K | $49.0K | $39.0K | $37.0K | · | · | · | $-888.0K | $-654.0K | $-350.0K | |
| Stockholders' Equity | $-31M | $-12M | $20M | $34M | $65M | $33M | $31M | $3M | $4M | $10M | $10M | |
| Liabilities + Equity | $26M | $35M | $75M | $100M | $160M | $55M | $40M | $10M | $10M | $14M | $13M | |
| Shares Outstanding | 28,683,000 | 17,453,000 | 8,261,000 | 5,932,000 | 92,232,000 | 69,117,000 | 57,032,000 | 40,664,000 | 31,452,000 | 28,737,000 | 25,391,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $800.0K | $313.0K | · | · | · | · | · | |
| Stock-based Comp | $2M | $2M | $3M | $10M | $7M | $5M | $3M | $1M | $2M | · | · | |
| Deferred Tax | · | · | $0 | $0 | $-9M | $-1M | · | · | · | · | · | |
| Amort. of Intangibles | $7.0K | $88.0K | $88.0K | $4M | $3M | $81.0K | · | $121.0K | $242.0K | $242.0K | $242.0K | |
| Other Non-cash | $24M | $37M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-22M | $-21M | $-23M | $-46M | $-36M | $-26M | $-20M | $-12M | $-13M | $-8M | $-4M | |
| CapEx | $3M | $516.0K | $281.0K | $4M | $2M | $1M | $918.0K | $31.0K | $91.0K | $106.0K | $500.0K | |
| Investing Cash Flow | $-3M | $-512.0K | $-932.0K | $-4M | $-14M | $-12M | $-12M | $-31.0K | $843.0K | $-181.0K | $315.0K | |
| Debt Issued | · | · | · | · | · | $1M | · | · | · | · | · | |
| Stock Issued | $29M | $26M | $14M | $33M | $65M | $18M | $49M | $10M | · | $0 | $12M | |
| Net Stock Activity | $29M | $26M | $14M | · | · | · | · | · | · | $0 | · | |
| Financing Cash Flow | $28M | $20M | $12M | $36M | $78M | $23M | $48M | $12M | $10M | $10M | $12M | |
| Net Change in Cash | $3M | $-796.0K | $-12M | $-14M | $28M | $-15M | $16M | $434.0K | $-3M | $2M | $8M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-25M | $-21M | $-24M | · | · | · | · | · | · | $-8M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.7% | 39.3% | 27.5% | · | · | · | · | · | · | · | · | |
| Operating Margin | -1260.8% | -3245.1% | -1672.4% | · | · | · | · | · | · | 39785.7% | · | |
| Net Margin | -1238.5% | -3225.0% | -1848.4% | · | · | · | · | · | · | 39885.7% | · | |
| Pretax Margin | · | -3225.0% | -1653.7% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1206.6% | -3162.0% | -1672.4% | · | · | · | · | · | · | 39785.7% | · | |
| ROA | -165.1% | -110.3% | -31.8% | · | · | · | · | · | · | -82.2% | · | |
| ROE | 330.8% | 4733.8% | -98.2% | · | · | · | · | · | · | -110.1% | · | |
| ROIC | · | 497.3% | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.6 | 1.5 | · | · | · | · | · | · | 3.0 | · | |
| Quick Ratio | 1.1 | 1.4 | 1.4 | · | · | · | · | · | · | 2.4 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | · | · | · | · | · | · | -0.0 | · | |
| Inventory Turnover | 4.1 | 5.1 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 3.0 | 1.8 | 2.8 | · | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.10 | $-0.70 | $2.48 | · | · | · | · | · | · | $0.34 | · | |
| Revenue / Share | $0.13 | $0.14 | $0.20 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.73 | $-1.58 | $-3.05 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.40 | $0.49 | $1.14 | · | · | · | · | · | · | $0.35 | · | |
| EPS (TTM) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · | · | · | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 115.6% | 25.1% | 56.9% | -56.4% | 80.8% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 61.8% | -5.1% | 7.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 27.2% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $2M | $2M | $958.0K | $2M | $1M | · | · | · | · | $0 | |
| Net Income TTM | $-50M | $-61M | $-28M | $-73M | $-64M | $-30M | $-22M | $-16M | $-19M | $-11M | $-9M | |
| Market Cap | $215M | $42M | $21M | · | · | · | · | · | · | $4.05B | · | |
| P/E | -4.5 | -0.5 | -0.7 | -0.5 | · | · | · | · | · | · | · | |
| P/S | 53.1 | 22.1 | 13.7 | · | · | · | · | · | · | · | · | |
| P/B | -6.8 | -3.4 | 1.0 | · | · | · | · | · | · | 410.9 | · | |
| P / Tangible Book | · | · | · | · | · | 355.7 | · | · | · | · | · | |
| P / Cash Flow | -9.7 | -2.0 | -0.9 | · | · | · | · | · | · | -538.7 | · | |
| P / FCF | -8.5 | -2.0 | -0.9 | · | · | · | · | · | · | -531.2 | · | |
| Earnings Yield | -22.0% | -195.8% | -150.0% | -206.4% | · | · | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239.0K | $32.0K | $1M | $260.0K | $518.0K | $2M | $1M | $115.0K | $104.0K | $176.0K | $314.0K | $429.0K | $463.0K | $297.0K | $274.0K | $67.0K | |
| Cost of Revenue | $82.0K | $17.0K | $655.0K | $121.0K | $180.0K | $813.0K | $869.0K | $43.0K | $32.0K | $109.0K | $409.0K | $159.0K | $169.0K | $265.0K | $278.0K | $314.0K | |
| Gross Profit | $157.0K | $15.0K | $484.0K | $139.0K | $338.0K | $1M | $595.0K | $50.0K | $50.0K | $45.0K | $-117.0K | $248.0K | $272.0K | $10.0K | $-27.0K | $-269.0K | |
| R&D Expense | $4M | $5M | $6M | $4M | $3M | $3M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| SG&A Expense | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $4M | $3M | $5M | $6M | |
| Operating Expenses | $12M | $4M | $24M | $11M | $10M | $8M | $34M | $14M | $5M | $9M | $16M | $7M | $9M | $-6M | $12M | $1M | |
| Operating Income | $-11M | $-4M | $-23M | $-11M | $-10M | $-7M | $-34M | $-14M | $-5M | $-9M | $-16M | $-7M | $-8M | $6M | $-12M | $-2M | |
| Other Non-op | $162.0K | $146.0K | $506.0K | $223.0K | $125.0K | $157.0K | $146.0K | $53.0K | $110.0K | $153.0K | $269.0K | $127.0K | $-1.0K | $-1.0K | $-365.0K | $62.0K | |
| Pretax Income | · | · | · | · | · | · | · | $-13M | $-5M | $-9M | $-16M | $-6M | $-8M | $6M | $-12M | $-2M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-11M | $-4M | $-23M | $-11M | $-10M | $-7M | $-34M | $-13M | $-5M | $-9M | $-16M | $-6M | $-8M | $3M | $-45M | $-9M | |
| EPS (Basic) | $-0.31 | $-0.12 | $-0.75 | $-0.34 | $-0.30 | $-0.26 | $-2.19 | $-0.98 | $-0.36 | $-1.13 | $-2.27 | $-0.81 | $-1.07 | $0.40 | $-10.04 | $-1.62 | |
| EPS (Diluted) | $-0.31 | $-0.12 | $-0.75 | $-0.34 | $-0.30 | $-0.26 | $-2.19 | $-0.98 | $-0.36 | $-1.13 | $-2.27 | $-0.81 | $-1.07 | $0.40 | $-10.04 | $-1.62 | |
| Shares (Basic) | 36,750,000 | 34,519,000 | · | 32,033,000 | 32,023,000 | 25,694,000 | · | 13,714,000 | 12,870,000 | 8,264,000 | · | 8,256,000 | 8,090,000 | 5,958,000 | · | 5,931 | |
| Shares (Diluted) | 36,750,000 | 34,519,000 | · | 32,033,000 | 32,023,000 | 25,694,000 | · | 13,714,000 | 12,870,000 | 8,264,000 | · | 8,256,000 | 8,090,000 | 5,963,000 | · | 5,931 | |
| EBITDA | $-11M | $-4M | · | $-10M | $-9M | $-6M | · | $-14M | $-5M | $-9M | · | $-7M | $-8M | $6M | · | $-9M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $28M | $12M | $19M | $24M | $31M | $9M | $3M | $9M | $6M | $9M | $14M | $17M | $12M | $20M | $32M | |
| Receivables | $192.0K | $157.0K | $1M | $258.0K | $512.0K | $4M | $2M | $209.0K | $85.0K | $161.0K | $484.0K | $2M | $2M | $2M | $2M | $2M | |
| Inventory | $207.0K | $382.0K | $446.0K | $471.0K | $693.0K | $459.0K | $410.0K | $232.0K | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $1M | $821.0K | $627.0K | $595.0K | $735.0K | $643.0K | $672.0K | $1M | $970.0K | $977.0K | $2M | |
| Current Assets | $21M | $31M | $15M | $21M | $27M | $36M | $12M | $5M | $10M | $7M | $11M | $17M | $21M | $16M | $26M | $37M | |
| PP&E (Net) | $6M | $9M | $9M | $6M | $6M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $7M | $8M | $9M | $9M | |
| Accum. Depreciation | $8M | $10M | $10M | $9M | $8M | $7M | $8M | $7M | $7M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $19M | |
| Intangibles | · | · | $0 | $15M | $15M | $15M | $15M | $57M | $57M | $57M | $57M | $57M | $57M | $57M | $62M | $88M | |
| Other Non-current Assets | $556.0K | $574.0K | $593.0K | $672.0K | $702.0K | $642.0K | $691.0K | $699.0K | $563.0K | $438.0K | $463.0K | $520.0K | $329.0K | $367.0K | $371.0K | $366.0K | |
| Total Assets | $29M | $40M | $26M | $44M | $51M | $60M | $35M | $70M | $75M | $71M | $75M | $82M | $88M | $83M | $100M | $157M | |
| Accounts Payable | $2M | $2M | $3M | $1M | $1M | $2M | $2M | $872.0K | $1M | $908.0K | $953.0K | $1M | $875.0K | $1M | $1M | $2M | |
| Accrued Liabilities | $2M | $3M | $2M | $2M | $1M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $4M | |
| Current Liabilities | $10M | $12M | $12M | $8M | $7M | $10M | $7M | $9M | $7M | $8M | $7M | $8M | $8M | $9M | $12M | $13M | |
| Total Liabilities | $51M | $51M | $57M | $53M | $49M | $50M | $47M | $61M | $52M | $54M | $49M | $39M | $39M | $39M | $60M | $75M | |
| Common Stock | $395M | $394M | $369M | $369M | $368M | $367M | $338M | $327M | $326M | $311M | $310M | $310M | $310M | $296M | $295M | $293M | |
| Retained Earnings | $-416M | $-405M | $-401M | $-378M | $-367M | $-357M | $-351M | $-317M | $-304M | $-299M | $-290M | $-272M | $-266M | $-258M | $-261M | $-216M | |
| AOCI | $67.0K | $71.0K | $86.0K | $86.0K | $85.0K | $41.0K | $21.0K | $57.0K | $37.0K | $40.0K | $49.0K | $32.0K | $41.0K | $43.0K | $39.0K | $19.0K | |
| Stockholders' Equity | $-21M | $-11M | $-31M | $-9M | $1M | $10M | $-12M | $10M | $23M | $12M | $20M | $38M | $44M | $38M | $34M | $77M | |
| Liabilities + Equity | $29M | $40M | $26M | $44M | $51M | $60M | $35M | $70M | $75M | $71M | $75M | $82M | $88M | $83M | $100M | $157M | |
| Shares Outstanding | 32,623,000 | 32,286,000 | 28,683,000 | 28,625,000 | 28,617,000 | 28,599,000 | 17,453,000 | 13,374,000 | 13,368,000 | 8,273,000 | 8,261,000 | 8,261,000 | 8,241,000 | 119,279,000 | 5,932,000 | 118,619,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $665.0K | $631.0K | $563.0K | $584.0K | $559.0K | $491.0K | $563.0K | $340.0K | $326.0K | $335.0K | $303.0K | $404.0K | $435.0K | $450.0K | $466.0K | $391.0K | |
| Stock-based Comp | $661.0K | $615.0K | $721.0K | $521.0K | $504.0K | $473.0K | $499.0K | $450.0K | $386.0K | $418.0K | $484.0K | $608.0K | $834.0K | $834.0K | $3M | $3M | |
| Amort. of Intangibles | $0 | $0 | $0 | $0 | $0 | $7.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $812.0K | $976.0K | |
| Other Non-cash | · | $-5M | · | · | · | $-151.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-6M | $-5M | $-6M | $-6M | $-5M | $-6M | $-6M | $-4M | $-4M | $-2M | $-5M | $-8M | $-10M | $-11M | |
| CapEx | $779.0K | $613.0K | $1M | $1M | $349.0K | $307.0K | $214.0K | $87.0K | $191.0K | $24.0K | $264.0K | · | · | · | $802.0K | $859.0K | |
| Investing Cash Flow | $-779.0K | $-613.0K | $-1M | $-1M | $-349.0K | $-307.0K | $-210.0K | $-87.0K | $-191.0K | $-24.0K | $103.0K | $-1M | $123.0K | $-1M | $-802.0K | $-859.0K | |
| Stock Issued | $0 | $26M | $0 | $0 | $0 | $29M | $10M | $0 | $16M | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $26M | · | · | · | $29M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-564.0K | $25M | $-252.0K | $-120.0K | $-114.0K | $29M | $11M | $-255.0K | $10M | $0 | $-30.0K | $-30.0K | $12M | $-28.0K | $-100.0K | $-572.0K | |
| Net Change in Cash | $-11M | $16M | $-7M | $-6M | $-7M | $22M | $5M | $-6M | $4M | $-4M | $-4M | $-4M | $6M | $-10M | $-11M | $-13M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-8M | · | · | · | $-6M | · | · | · | $-4M | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.7% | 46.9% | · | 53.5% | 67.6% | 62.0% | · | 43.5% | 48.1% | -55.7% | · | 57.8% | 58.8% | 3.4% | · | -115.4% | |
| Operating Margin | -4770.7% | -13790.6% | · | -4249.2% | -1900.0% | -318.0% | · | -11752.2% | -4453.9% | -5265.3% | · | -1518.2% | -1791.4% | 1952.2% | · | -906.7% | |
| Net Margin | -4711.3% | -13406.2% | · | -4174.6% | -1880.7% | -312.0% | · | -11733.0% | -4355.8% | -5186.9% | · | -1512.6% | -1799.8% | 1021.2% | · | -917.7% | |
| Pretax Margin | · | · | · | · | · | · | · | -11733.0% | -4355.8% | -5186.9% | · | -1512.6% | -1799.8% | 2006.4% | · | -917.7% | |
| EBITDA Margin | -4492.5% | -11818.8% | · | -4024.6% | -1792.1% | -295.0% | · | -11752.2% | -4453.9% | -5265.3% | · | -1518.2% | -1791.4% | 1952.2% | · | -906.7% | |
| ROA | -28.2% | -8.5% | · | -19.0% | -15.6% | -10.2% | · | -17.8% | -5.6% | -11.9% | · | -5.4% | -6.4% | 2.6% | · | -5.7% | |
| ROE | 111.5% | 1814.0% | · | -4215.1% | -81.9% | -61.2% | · | -57.1% | -13.7% | -36.9% | · | -11.3% | -13.1% | 6.4% | · | -10.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.5 | · | 2.8 | 4.0 | 3.7 | · | 0.5 | 1.4 | 0.8 | · | 2.1 | 2.7 | 1.7 | · | 2.8 | |
| Quick Ratio | 1.7 | 2.4 | · | 2.5 | 3.7 | 3.6 | · | 0.4 | 1.3 | 0.7 | · | 2.0 | 2.5 | 1.5 | · | 2.6 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.2 | 0.0 | · | 0.3 | 0.5 | 3.5 | · | 0.4 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.7 | 0.0 | · | 1.1 | 1.7 | 1.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.3 | 0.1 | · | 0.7 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.65 | $-0.33 | · | $-0.32 | $0.04 | $0.36 | · | $0.73 | $1.70 | $1.40 | · | $4.55 | $5.29 | $0.32 | · | $0.65 | |
| Revenue / Share | $0.01 | $0.00 | · | $0.01 | $0.02 | $0.08 | · | $0.01 | $0.01 | $0.02 | · | $51.96 | $57.23 | $0.00 | · | · | |
| Cash Flow / Share | · | $-0.22 | · | · | · | $-0.23 | · | · | · | $-0.46 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.54 | $0.87 | · | $0.65 | $0.85 | $1.08 | · | $0.25 | $0.69 | $0.67 | · | $1.67 | $2.11 | $0.10 | · | $0.27 | |
| EPS (TTM) | $-1.52 | $-1.51 | · | $-3.09 | $-3.73 | $-3.79 | · | $-4.74 | $-4.57 | $-5.28 | · | $-11.52 | $-12.33 | $-12.74 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $4M | $4M | $4M | · | $709.0K | $1M | $1M | · | $1M | $1M | $875.0K | · | $-1M | |
| Net Income TTM | $-49M | $-48M | · | $-61M | $-63M | $-58M | · | $-43M | $-36M | $-40M | · | $-57M | $-60M | $-60M | · | $-64M | |
| Market Cap | $192M | $106M | · | $95M | $86M | $88M | · | $38M | $39M | $24M | · | $26M | $38M | $844M | · | $1.73B | |
| P/E | -3.9 | -2.2 | · | -1.1 | -0.8 | -0.8 | · | -0.6 | -0.6 | -0.6 | · | -0.3 | -0.4 | -0.6 | · | · | |
| P/S | 115.3 | 54.3 | · | 21.6 | 20.3 | 22.8 | · | 53.8 | 38.5 | 17.5 | · | 17.6 | 34.4 | 965.1 | · | -1378.9 | |
| P/B | -9.0 | -9.9 | · | -10.3 | 78.7 | 8.6 | · | 3.9 | 1.7 | 2.1 | · | 0.7 | 0.9 | 22.3 | · | 22.5 | |
| P / Cash Flow | · | -13.9 | · | · | · | -14.9 | · | · | · | -6.3 | · | · | · | -87.3 | · | · | |
| Earnings Yield | -25.8% | -46.0% | · | -93.1% | -123.5% | -123.9% | · | -166.3% | -154.9% | -180.2% | · | -369.2% | -268.0% | -179.9% | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $4M | $2M | $2M | $958.0K | $2M |
| Bruttogewinnmarge % | 56.7% | 39.3% | 27.5% | · | · |
| Betriebsgewinnmarge % | -1260.8% | -3245.1% | -1672.4% | · | · |
| Nettoergebnis | $-50M | $-61M | $-28M | $-73M | $-64M |
| Verwässerte EPS | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.3 | 1.6 | 1.5 | · | · |
| Quick Ratio | 1.1 | 1.4 | 1.4 | · | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-25M | $-21M | $-24M | · | · |
Institutionelle Eigentümer (13F) 43 Einreicher · $111.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
43
Gehaltener Wert
$111.8M
Neue Positionen
11
Geschlossene Positionen
13
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 11 (-6 vs. Vorquartal) | 13 (+6 vs. Vorquartal) | 10 (-1 vs. Vorquartal) | 8 (+2 vs. Vorquartal) | -474K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BROADWOOD CAPITAL INC | $74.840.816 | 12.684.884 | 66,93% | Aktien |
| AWM Investment Company, Inc. | $16.736.483 | 2.836.692 | 14,97% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.341.497 | 735.847 | 3,88% | Aktien |
| VANGUARD GROUP INC | $3.950.064 | 526.675 | 3,53% | Aktien |
| PURA VIDA INVESTMENTS, LLC | $2.860.585 | 484.845 | 2,56% | Aktien |
| Family Office Research LLC | $2.176.207 | 368.849 | 1,95% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.516.953 | 256.903 | 1,36% | Aktien |
| JANE STREET GROUP, LLC | $930.324 | 157.682 | 0,83% | Aktien |
| BlackRock, Inc. | $888.074 | 150.521 | 0,79% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $734.998 | 124.576 | 0,66% | Aktien |
| STATE STREET CORP | $543.532 | 92.124 | 0,49% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $486.744 | 82.499 | 0,44% | Aktien |
| UBS Group AG | $314.329 | 53.276 | 0,28% | Aktien |
| NORTHERN TRUST CORP | $289.631 | 49.090 | 0,26% | Aktien |
| OSAIC HOLDINGS, INC. | $230.901 | 39.136 | 0,21% | Aktien |
| MORGAN STANLEY | $209.539 | 35.515 | 0,19% | Aktien |
| Jefferies Financial Group Inc. | $106.790 | 18.100 | 0,10% | Aktien |
| MARSHALL WACE, LLP | $97.922 | 16.597 | 0,09% | Aktien |
| ExodusPoint Capital Management, LP | $82.771 | 14.029 | 0,07% | Aktien |
| AXQ CAPITAL, LP | $79.101 | 13.407 | 0,07% | Aktien |
| Flatrock Wealth Partners LLC | $76.960 | 13.044 | 0,07% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $65.496 | 11.101 | 0,06% | Aktien |
| XTX Topco Ltd | $63.384 | 10.743 | 0,06% | Aktien |
| Private Advisor Group, LLC | $61.454 | 10.416 | 0,05% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $34.226 | 5.801 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $34.073 | 5.775 | 0,03% | Aktien |
| EverSource Wealth Advisors, LLC | $29.500 | 5.000 | 0,03% | Aktien |
| Tower Research Capital LLC (TRC) | $15.877 | 2.691 | 0,01% | Aktien |
| Steward Partners Investment Advisory, LLC | $11.564 | 1.960 | 0,01% | Aktien |
| ORG Partners LLC | $3.375 | 450 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $1.092 | 185 | 0,00% | Aktien |
| FNY Investment Advisers, LLC | $1.077 | 182.561 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $1.000 | 251 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $835 | 154 | 0,00% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $340 | 63 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $266 | 45 | 0,00% | Aktien |
| Piscataqua Savings Bank | $147 | 25 | 0,00% | Aktien |
| ALBION FINANCIAL GROUP /UT | $42 | 7 | 0,00% | Aktien |
| WELLS FARGO & COMPANY/MN | $41 | 7 | 0,00% | Aktien |
| Cassaday & Co Wealth Management LLC | $36 | 6 | 0,00% | Aktien |
| Global Retirement Partners, LLC | $6 | 1 | 0,00% | Aktien |
| Farther Finance Advisors, LLC | $6 | 1 | 0,00% | Aktien |
| Motiv8 Investments LLC | $0 | 10 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher ×15 Einreichungen | 27. April 2026 | 39,70% | Änderung | Passive Anlage | SEC |
| Lineage Cell Therapeutics, Inc. 1 S.S. OR ×4 Einreichungen | 8. Januar 2021 | · | Erste Einreichung | · | SEC |
| BioTime, Inc. 1 S.S. OR ×5 Einreichungen | 5. Juli 2019 | · | Erste Einreichung | · | SEC |
| BioTime, Inc. S.S. OR | 29. August 2016 | · | Erste Einreichung | Vorstandskampagne | SEC |
| BioTime, Inc. | 31. Dezember 2015 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 29 Insider · 16 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Josh Riggs | CEO and President | 26. März 2026 M | 38.365 | 0 | 0 | $0 |
| Ronald Asbury Andrews | Former CEO | 7. Dezember 2022 A | 583.212 | 0 | 0 | $0 |
| William Annett | President and CEO | 14. März 2019 A | 3.500 | 0 | 0 | $0 |
| Andrea S. James | Chief Financial Officer | 26. März 2026 M | 206.060 | 0 | 0 | $0 |
| Anish M. John | Chief Financial Officer | 24. Februar 2023 A | 150.000 | 0 | 0 | $0 |
| Mitchell S Levine | Chief Financial Officer | 15. März 2022 A | 87.080 | 0 | 0 | $0 |
| Gisela Paulsen | Former President and COO | 16. Dezember 2022 D | 366.500 | 0 | 0 | $0 |
| Albert P Parker | COO | 11. Dezember 2020 A | 10.586 | 0 | 0 | $0 |
| James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | 26. März 2026 M | 3.711 | 0 | 0 | $0 |
| Douglas T. Ross | Former CSO | 21. Dezember 2022 A | 234.114 | 0 | 0 | $0 |
| Li Yu | VP Cntrllr/Prncpl Acctng Offcr | 18. Mai 2022 M | 16.872 | 0 | 0 | $0 |
| Padma Sundar | Chief Commercial Officer | 15. März 2022 A | 4.177 | 0 | 0 | $0 |
| Lyndal K. Hesterberg | CSO | 11. Dezember 2020 A | 7.477 | 0 | 0 | $0 |
| Tony T Kalajian | Sr.VP/Chief Accounting Officer | 3. August 2020 P | 15.000 | 0 | 0 | $0 |
| Kristine C. Mechem | VP of Marketing | 7. Juni 2018 A | · | 0 | 0 | $0 |
| Karen B. Chapman | Vice President of Research | 16. Februar 2016 A | · | 0 | 0 | $0 |
| Andrew J. Last | Direktor | 1. Juli 2026 F | 58.752 | 0 | 0 | $0 |
| Andrew Arno | Direktor | 1. Juli 2026 F | 156.785 | 0 | 0 | $0 |
| Lou Silverman | Direktor | 1. Juli 2026 F | 55.807 | 0 | 0 | $0 |
| Alfred D Kingsley | Direktor | 23. Juni 2023 A | 489.111 | 0 | 0 | $0 |
| Jennifer L. Carter | Direktor | 15. August 2022 A | 30.500 | 0 | 0 | $0 |
| Melinda Griffith | Direktor | 15. August 2022 A | 30.000 | 0 | 0 | $0 |
| Cavan M. Redmond | Direktor | 24. Juni 2022 M | 120.863 | 0 | 0 | $0 |
| Aditya P. Mohanty | Direktor | 17. Juli 2019 A | · | 0 | 0 | $0 |
| Don M Bailey | Direktor | 15. Juni 2017 A | · | 0 | 0 | $0 |
| Michael D West | Direktor | 16. Februar 2016 A | · | 0 | 0 | $0 |
| Patrick W Smith | 10%-Eigentümer | 7. Februar 2025 J | 3.258.485 | 0 | 0 | $0 |
| John Peter Gutfreund | · | 30. Juni 2023 J | 0 | 0 | 0 | $0 |
| BIOTIME INC | · | 2. Januar 2020 S | 6.041.154 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
IMDX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 11 Analysten
KAUF
Median-Ziel
$8.50
+147,1%
2 18,2%
Starker Kauf
6 54,5%
Kauf
3 27,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-09-29Mittelwert-Ziel $8.25 +139,8%
← Unter allen Zielen
Aktueller Preis $3.44
Tief$4.00
Mittelwert$8.25
Hoch$12.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
| HURA | · | -1.2 | · | · | · | · |
| VTVT | · | · | · | · | -70.4% | · |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 10, 2026